Librela (bedinvetmab) is a prescription-only, monthly injection that targets nerve growth factor (anti‑NGF monoclonal antibody) to help control osteoarthritis (arthritis/degenerative joint) pain. In the United States, Librela is approved for dogs only—not for cats.
For cats, the comparable medication is Solensia (frunevetmab), an anti‑NGF monoclonal antibody approved to control pain from osteoarthritis. If an owner asks about “Librela for a cat,” it may be a name mix‑up; please confirm the medication and species in the chart. Your veterinarian can discuss which option is appropriate for the pet.
Front desk script: Thanks for asking—Librela is a prescription antibody injection for arthritis pain, but it’s approved for dogs. For cats, we use Solensia, a similar antibody medication for osteoarthritis pain. Let me double‑check your pet’s chart to confirm which one was ordered. Our veterinarian can go over which medicine is appropriate for your cat and answer any medical questions.
Key point: Librela (bedinvetmab) is FDA‑approved for dogs only. There is no Librela product approved for cats. For cats with osteoarthritis pain, the approved anti‑NGF antibody is Solensia (frunevetmab). If a cat received a monthly arthritis injection at our clinic, it would be Solensia unless the veterinarian states otherwise.
Common owner FAQs
Q: Can my cat get Librela? A: No—Librela is labeled for dogs. Your veterinarian can discuss Solensia, which is the approved option for cats.
Q: Is Solensia the same as Librela? A: They work in a similar way (antibody treatments that block a pain signal called NGF), but Solensia is made for cats and Librela is made for dogs; your veterinarian can advise which is appropriate.
Q: What side effects should I watch for after my cat’s arthritis shot? A: With Solensia, mild vomiting or temporary injection‑site soreness are most common; some cats can develop scabbing/itching of the head or neck. If you see trouble breathing, facial swelling, collapse, severe vomiting/diarrhea, or seizures, go to the nearest emergency vet now and call us.
Q: If Solensia isn’t helping, can we try Librela? A: That’s a medical question for the veterinarian. Librela isn’t approved for cats; please schedule a recheck so the doctor can discuss next steps and alternatives.
Q: How soon will my cat feel better? A: Some cats improve after the first monthly dose, while others need more time; your veterinarian can set expectations for your pet.
Front desk script: Thanks for checking—Librela is the dog version. For cats, the FDA‑approved monthly injection is Solensia. Mild vomiting or a little soreness can happen after Solensia; if you notice trouble breathing, facial swelling, collapse, severe vomiting/diarrhea, or seizures, go to the nearest emergency vet now and call us. For questions about switching treatments or what’s best for your cat, the veterinarian can discuss options at a recheck.
Important: As of February 22, 2026, Librela (bedinvetmab) is FDA‑approved for dogs only and is not labeled for use in cats. For cats, the anti‑NGF product approved for osteoarthritis pain is Solensia (frunevetmab). Because bedinvetmab isn’t approved for cats, there is no label‑based list of “expected” side effects in cats. If an owner says their cat received “Librela,” confirm the exact product administered in our records before advising next steps. Your veterinarian can discuss risks and what’s appropriate for that patient.
After any injection, some cats can have mild, short‑lived reactions like being a little tired or a small, tender bump at the injection site; however, for bedinvetmab in cats we do not have established guidance on what is “normal.” Treat any new or worsening signs after an injection in a cat as reportable. Escalate immediately if the owner reports emergency signs such as trouble breathing, facial swelling, collapse, or seizures; these can indicate a severe allergic reaction and need urgent veterinary care. For concerning but non‑emergency signs (repeated vomiting/diarrhea, not eating, marked lethargy, or a hot/painful swelling at the injection site), arrange a same‑day veterinarian call‑back or appointment. Your veterinarian can advise on whether the cat should be seen urgently.
Front desk script: Thank you for calling—let me first confirm exactly which injection your cat received at our clinic: Solensia (for cats) or Librela (for dogs). If your cat is having trouble breathing, facial swelling, collapse, or seizures right now, please proceed to the nearest emergency clinic immediately while I alert our veterinarian. If you’re seeing repeated vomiting or diarrhea, not eating, extreme tiredness, or a hot, painful lump at the injection site, I’ll arrange a same‑day call with our veterinarian or a visit. Our doctor will review your cat’s case and advise on next steps.
Librela (bedinvetmab) is a clinic-only injection; pet owners do not give this at home. It is FDA-approved for dogs, not cats. For cats with osteoarthritis pain, the labeled anti‑NGF option is Solensia (frunevetmab), which is also a once‑monthly injection administered by the veterinary team. If a caller says their cat was prescribed “Librela,” please confirm the exact product with the veterinarian before scheduling, as product names can be confused.
Because this medication is given by our staff, there are no pilling tricks or food‑with/without instructions. After any injection, if the cat seems unwell (e.g., vomiting, not acting normal), advise the owner to contact the clinic the same day for guidance. If the cat develops trouble breathing, facial swelling, or hives after an injection, direct them to seek emergency care immediately. Questions about which product is appropriate, timing of injections, or any side effects should be addressed by the veterinarian.
Front desk script: This medicine is a monthly injection that’s given here by our veterinary team—there’s nothing to give at home. Librela is approved for dogs; for cats, the labeled option is Solensia. Let me confirm which product your cat is scheduled to receive and set up the injection visit. If your cat has vomiting or seems off after an injection, please call us the same day; if there’s facial swelling or trouble breathing, go to an emergency clinic right away. The veterinarian can answer any specific safety or product questions.
Important: In the U.S., Librela (bedinvetmab) is FDA‑approved for dogs, not cats. For cats with osteoarthritis pain, the FDA‑approved anti‑NGF monoclonal antibody is Solensia (frunevetmab), which is a once‑monthly injection given in the clinic. If a caller requests a "Librela refill" for a cat, first confirm the actual product on the pet’s record and proceed as an in‑clinic injection scheduling request for the veterinarian‑prescribed feline product.
Refill workflow: 1) Verify patient (pet name, DOB), prescribing veterinarian, and exact product on file; 2) Ask last injection date and any side effects or concerns since the last dose; 3) Check whether a recheck exam is due per the veterinarian’s plan before further injections; 4) Offer the next available nurse/tech injection slot (turnaround usually same week depending on schedule). These injections are clinic‑administered only and are not filled through outside/online pharmacies; if an online pharmacy request arrives, mark “clinic‑administered only—no dispensing,” notify the client, and offer to schedule. Typical interval for the approved feline product is every 4 weeks, but timing and continuation are set by the veterinarian.
Escalation: If the caller reports severe weakness, collapse, trouble walking, difficulty breathing, or seizure‑like activity after any injection, transfer to a nurse/veterinarian immediately; if after hours, direct the client to emergency care. All clinical questions about safety, benefits/risks, or whether to continue therapy must be deferred to the veterinarian.
Front desk script: Thanks for calling about a refill for your cat. Just a heads‑up: Librela is the dog product; the FDA‑approved monthly injection for cats is called Solensia. Can I confirm which one your cat receives, the date of the last injection, and if you’ve noticed any problems since then? I’ll check your chart, see if a recheck is due, and schedule the next injection—these are given here in the clinic and aren’t filled through outside pharmacies. If your cat is having serious symptoms right now, please tell me so I can get a nurse or doctor on the line immediately.
Librela (bedinvetmab) is approved for dogs, not cats. If a cat received Librela by mistake or a caller is asking about giving a cat Librela, stop and get a veterinarian or technician immediately. For cats, the anti‑NGF product with label information is Solensia (frunevetmab); your veterinarian can discuss appropriate options and monitoring for that cat-specific medication. ([fda.gov](https://www.fda.gov/animal-veterinary/drug-labels/animal-drug-safety-related-labeling-changes))
Emergency red flags after any injection or suspected Librela exposure in a cat: facial swelling or hives, trouble breathing, collapse/fainting, or seizures — treat this as an emergency and escalate now. Urgent red flags that also require immediate veterinary evaluation include sudden hind‑limb weakness or paralysis, inability to urinate or loss of bladder control, severe vomiting/diarrhea, or profound lethargy. These neurologic, urinary, and gastrointestinal signs have been highlighted in post‑approval safety communications for Librela (in dogs) and severe allergic reactions (including anaphylaxis) are listed for the class in feline labeling for Solensia. Do not advise any dosing changes; a veterinarian must decide next steps. ([fda.gov](https://www.fda.gov/animal-veterinary/drug-labels/animal-drug-safety-related-labeling-changes))
If a cat is scheduled for, or currently on, Solensia and develops severe vomiting/diarrhea, marked lethargy, swelling at the face/throat, or any breathing difficulty, escalate to a veterinarian at once; your veterinarian can advise on risks, benefits, and monitoring for that specific patient. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a73b79c4-3623-4b52-81ea-6180528a031e&utm_source=openai))
Front desk script: “Librela is a dog‑only injection. Because this involves a cat, I’m getting our medical team on the line right now.” “If your cat has facial swelling, trouble breathing, collapses, or is having a seizure, this is an emergency—please head to the nearest emergency hospital now while I alert our veterinarian.” “If your cat received Librela by mistake or is suddenly very weak, stumbling, unable to urinate, or vomiting/has diarrhea, we need a veterinarian to assess this immediately.” “Your veterinarian can discuss the cat‑specific option, Solensia, and what to watch for going forward.”
Important species note: Librela (bedinvetmab) is labeled for dogs only. The anti‑NGF monoclonal antibody labeled for cats is Solensia (frunevetmab). If an owner says their cat is on “Librela,” or brings a Librela vial for a cat, pause and hand off to a veterinarian to confirm the product and plan before scheduling, dispensing, or administering anything. FDA materials and Zoetis communications specify Librela is for dogs; Solensia is for cats. ([fda.gov](https://www.fda.gov/animal-veterinary/cvm-updates/fda-approves-first-monoclonal-antibody-dogs-osteoarthritis-pain?utm_source=openai))
Interaction awareness for anti‑NGF therapy in cats (Solensia/frunevetmab): the label says concurrent use with NSAIDs has not been established; use with other monoclonal antibodies has not been evaluated; and potential interactions with vaccines were not evaluated. When owners mention other meds, flag the following for veterinarian review: NSAIDs (e.g., robenacoxib/Onsior, meloxicam), any other injectable biologics/mAbs, and recent vaccines. Commonly co‑prescribed or discussed alongside in feline OA care include gabapentin, buprenorphine products (e.g., Simbadol/Zorbium), short‑term peri‑operative NSAIDs like robenacoxib, and joint supplements/omega‑3s—capture exact product names and doses and route to the medical team for clearance. ([fda.report](https://fda.report/DailyMed/a73b79c4-3623-4b52-81ea-6180528a031e))
OTC/human meds to always flag: acetaminophen (Tylenol) and human NSAIDs such as ibuprofen (Advil/Motrin), naproxen (Aleve), and even owner‑applied topical NSAID creams (e.g., flurbiprofen/diclofenac) are dangerous for cats. If an owner already gave any of these, this is an emergency—immediate veterinary care is needed; you may also provide the ASPCA Animal Poison Control number. Urgent signs after these exposures include trouble breathing, brown/muddy gums, facial swelling, vomiting, extreme lethargy, or collapse. Your veterinarian can discuss safe combinations and whether any current meds need to be adjusted. ([merckvetmanual.com](https://www.merckvetmanual.com/toxicology/toxicoses-from-human-analgesics/toxicoses-from-human-analgesics-in-animals?utm_source=openai))
Front desk script: Thanks for calling. To confirm, Librela (bedinvetmab) is for dogs; the cat version of this therapy is called Solensia—let me have our veterinarian review exactly what your cat is receiving. Could you list every medication and supplement your cat is getting, including any recent injections, vaccines, flea/tick preventives, or pain meds? Please don’t start any human pain relievers; if your cat was given Tylenol, ibuprofen, or naproxen—or licked a human topical pain cream—this is an emergency; go to the nearest ER and you can also call ASPCA Poison Control at 888‑426‑4435. Our veterinarian will advise you on which medications are safe to use together.
Librela (bedinvetmab) vials must be kept refrigerated at 36–46°F (2–8°C), never frozen, and stored in the original carton to protect from light. Each vial is single‑use: once punctured, the contents should be used immediately and any remainder discarded. Librela is labeled for dogs; there is no bedinvetmab product labeled for cats in the U.S. at this time. This medication is administered in‑clinic by the veterinary team and is not typically dispensed to owners; confirm any exceptions with the veterinarian.
Handling reminders: keep all vials out of reach of children and pets. If a vial was frozen, left unrefrigerated, exposed to heat/light, or the packaging is damaged, do not use or hand it out—notify the veterinarian the same day. To avoid accidental self‑injection, handle with care; women who are pregnant, trying to conceive, or breastfeeding should take extra precautions. In case of accidental self‑injection, seek medical attention immediately and bring the product label.
Disposal: place used needles/syringes in a sharps container and discard any unused solution after first puncture. Dispose of unopened/expired vials per your hospital’s pharmaceutical waste procedures and local/state regulations. Your veterinarian can advise on clinic‑specific handling or transport questions.
Important: Librela (bedinvetmab) is FDA‑approved for dogs, not cats. It is a canine monoclonal antibody. For cats, the on‑label anti‑NGF option is Solensia (frunevetmab). Please verify with the veterinarian which product is intended before scheduling; any off‑label plan for a cat must come directly from the prescribing veterinarian. [Front‑desk note: do not substitute products without DVM confirmation.]
For cats receiving on‑label anti‑NGF therapy (Solensia), injections are administered in‑clinic about every 4 weeks. Book a brief check‑in with each injection to document mobility/comfort changes and any side effects. The FDA summary/label for Solensia do not specify routine bloodwork requirements; the veterinarian may recommend labs based on the cat’s age, other diseases, or concurrent medications. Your veterinarian can discuss the exact monitoring cadence, any baseline or follow‑up labwork, and when to reassess response.
Advise owners to call the clinic if they notice vomiting, diarrhea, decreased appetite, or new skin scabs/itching after an injection; schedule a same‑day nurse/doctor callback. Escalate immediately if the cat has facial swelling, trouble breathing, collapse, or a rapidly worsening reaction after an injection.
Front desk script: I want to confirm the exact medication with the doctor because Librela is labeled for dogs; the labeled anti‑NGF option for cats is called Solensia. Once the veterinarian confirms the plan, we’ll schedule in‑clinic injections about every four weeks, with a quick check‑in each visit to see how your cat is doing. Routine bloodwork isn’t required by the label, but the doctor may recommend labs based on your cat’s health. If you see severe or fast‑worsening signs like facial swelling or trouble breathing after any injection, please seek urgent care and call us right away.
Librela (bedinvetmab) is FDA‑approved for dogs to control osteoarthritis pain; it is not approved for cats in the U.S. For feline osteoarthritis pain, the FDA‑approved anti‑NGF monoclonal antibody is Solensia (frunevetmab). Any decisions about pain control for a cat should be made by the veterinarian after reviewing the pet’s history and exam findings.
If a caller reports severe signs after any injection (trouble breathing, facial swelling, collapse, repeated vomiting/diarrhea, or profound weakness), advise immediate emergency care and notify a veterinarian. Front desk staff should not give dosing advice, start/stop guidance, or compare products beyond stating their approved species; instead, offer to connect the client with a veterinarian.
Front desk script: Thank you for calling [Clinic Name], this is [Your Name]—I can help with your question about your cat. Just so you know, Librela (bedinvetmab) is FDA‑approved for dogs only; for cats, our veterinarians can discuss Solensia (frunevetmab) as an approved option. I can get a veterinarian on the line or schedule the next available consult to review what’s best for your cat. If your cat has trouble breathing, facial swelling, collapse, or severe vomiting/diarrhea after any injection, please go to the nearest emergency clinic now and we’ll alert our doctor. To avoid confusion, please don’t say “Librela is the same as Solensia” or ask for dosing—our veterinarian will go over safety and next steps.